Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New registry tracks Real-World use of myriad™ in wound reconstruction

NCT ID NCT05243966

Knowledge-focused Sponsor: Aroa Biosurgery Limited Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This observational study follows 800 adults who receive Myriad™ during soft tissue reconstruction for wounds like abdominal dehiscence, pressure injuries, or anal fistulas. Researchers track healing time, complications, and side effects to understand how well the material works in real-world surgeries. No new treatment is given—just careful monitoring of standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 800 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2022

Expected to finish

Jan 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study is being carried out at approximately 10 sites in the U.S. Across all sites, about 300 individuals will participate in the study where the Investigator is planning to utilize Myriad™ as a part of their surgical procedure.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Willing and able to provide written informed consent and to comply with the requirements of Clinical Investigational Plan * Male or female patients aged 18 years or above * Patients where Matrix and/or Morcells were used as part of their soft tissue reconstruction procedure * Subject that are willing and able to comply with all aspects of the treatment and evaluation schedule Exclusion Criteria: * Patients with known sensitivity to ovine (sheep) derived material * Patients with full thickness ('third degree') burns * Patients with wounds with uncontrolled clinical infection (CDC Contamination Grade=4) * Any medical condition or serious intercurrent illness that, in the opinion of the investigator, may make it undesirable for the patient to participate in the study * Patient is currently participating or has participated in another clinical study within past 30 days prior to enrollment * Pregnant or lactating women * Any subject who, at the discretion of the Investigator, is not suitable for inclusion in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abdominal wound dehiscence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anal fistula decubitus ulcer hidradenitis suppurativa necrotizing soft tissue infection pilonidal sinus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Abdominal wound dehiscence Anal fistula Hidradenitis suppurativa Lower extremity wound Necrotizing soft tissue infection Pilonidal sinus Pressure injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    12 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Asencion Sacred Heart

    RECRUITING

    Pensacola, Florida, 32504, United States

  • Associates in Medicine & Surgery

    ACTIVE_NOT_RECRUITING

    Fort Myers, Florida, 33919, United States

  • Lancaster General Hospital

    RECRUITING

    Lancaster, Pennsylvania, 17601, United States

  • Moses H Cone Memorial Hospital Operating Corporation

    COMPLETED

    Greensboro, North Carolina, 27401-1004, United States

  • Northeast Georgia Medical Center, Inc.

    RECRUITING

    Gainesville, Georgia, 30501, United States

  • Nuvance Health Vassar Brothers Medical Center

    ENROLLING_BY_INVITATION

    Poughkeepsie, New York, 12601, United States

  • Ochsner Baptist Medical Center

    ENROLLING_BY_INVITATION

    New Orleans, Louisiana, 70115, United States

  • Ohio State University Wexner Medical Center

    ENROLLING_BY_INVITATION

    Columbus, Ohio, 43210, United States

  • Sinai Hospital of Baltimore

    RECRUITING

    Baltimore, Maryland, 21215, United States

  • Surgery Group LA

    COMPLETED

    Los Angeles, California, 90048, United States

  • The Diane & Bruce Halle Arizona Burn Center at Valleywise Health

    ENROLLING_BY_INVITATION

    Phoenix, Arizona, 85008, United States

  • The Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Tower Health Reading Hospital

    ENROLLING_BY_INVITATION

    West Reading, Pennsylvania, 19611, United States

  • University Medical Center

    RECRUITING

    New Orleans, Louisiana, 70112, United States

  • University of IOWA Health Care

    ENROLLING_BY_INVITATION

    Iowa City, Iowa, 52242, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.